Longitudinal Lung Function Effects of Particulate Matter in Children with Cystic Fibrosis
-
2011/01/01
-
Details
-
Personal Author:
-
Description:Background/Aims: Chronic exposure to ambient-source particulate matter (PM) is associated with decreased lung function growth in healthy children. Children with cystic fibrosis (CF) have decreased lung function and decreased lung function growth, compared to normal children, and may be highly susceptible to the adverse chronic effects of air pollution exposure. Methods: Data were obtained from the Cystic Fibrosis Foundation Patient Registry. Included were Caucasian children 6-18 years of age with at least 1 spirometry measure from 1994 to 2006. Ambient levels of PM less than 2.5 um in diameter (PM2.5) and less than 10 um in diameter (PM10) were obtained from the US Environmental Protection Agency and estimated using year 2000 annual average concentration at the closest population-based monitor within 30 miles of the patient's home zip code centroid. FVC and FEV1 were regressed on age-adjusted height, age, year of birth (cohort effect), and 2-way interactions, using linear spline models including cross-sectional effects at age 6, stratified by gender. Results: A total of 5204 (54.0%) patients lived within 30 miles of a PM2.5 monitor and 2892 (30.2%) lived within 30 miles of a PM10 monitor. Annual average PM2.5 ranged from 5.5 to 28.2 ug/m3 for males and 3.8-28.2 ug/m3 for females. PM10 annual average ranged from 12.2-52.0 ug/m3 for males and 12.2-83.2 ug/m3 for females. A 10 ug/m3 increase in PM2.5 exposure was associated with a 10.10mL/yr (95% CI: -19.93, -0.32) decrement in FEV1 for males and 10.10 mL/yr (95% CI: -18.29, -1.91) in females. 10-year trend due to cohort effect was associated with a 5.91mL/yr (95% CI: -2.20, 14.02) and a 7.02 mL/yr (95% CI: 0.13, 13.90) increase in FEV1 in males and females, respectively. A 10 ug/m3 increase in PM10 was not found to be significantly associated with reduced lung function growth. Conclusion: Chronic exposure to ambient PM2.5 is associated with decreased lung function growth in children with cystic fibrosis. This effect is greater than the increase in FEV1 and FVC associated with longitudinal treatment trends. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1044-3983
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:22
-
Issue:1
-
NIOSHTIC Number:nn:20054896
-
Citation:Epidemiology 2011 Jan; 22(1)(Jan Suppl 2011):S200
-
Federal Fiscal Year:2011
-
Performing Organization:University of Washington
-
Peer Reviewed:False
-
Start Date:20050701
-
Source Full Name:Epidemiology
-
Supplement:Jan Suppl 2011
-
End Date:20250630
-
Collection(s):
-
Main Document Checksum:urn:sha-512:61d2328ffe61c67f39871196d3d00323707d74bcb975ac0140ddbbbe32c6e6316f6ea9bdad63f89ac9b50fd38ac5fec754d6036bc22a5aafdc4166d15464149c
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like